Which hedge funds own GLUE? MONTE ROSA THERAPEUTICS INC, Q2 2026 13F holders
8 of the hedge funds tracked by WhaleCreep disclosed a position in GLUE (MONTE ROSA THERAPEUTICS INC) in their Q2 2026 13F filings, worth $170.1m in total. The largest holder by portfolio weight is Suvretta Capital Management at 1.8% of its book. 1 manager opened a new position this quarter: Duquesne Family Office LLC. 1 exited: Millennium Management.
8tracked managers holding
1opened this quarter
1exited this quarter
Which hedge funds hold GLUE? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Suvretta Capital Management | Q2 2026 | 1.8% | $85.9m | 3,549,539 | -16% | reduced |
| Casdin Capital | Q2 2026 | 0.2% | $4.5m | 186,014 | 0% | held |
| Duquesne Family Office LLC | Q2 2026 | 0.2% | $7.2m | 297,600 | – | new |
| Woodline Partners | Q2 2026 | 0.1% | $23.3m | 962,884 | 1193% | added |
| Marshall Wace | Q2 2026 | 0.0% | $38.6m | 1,593,600 | 11% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.0% | $2.5m | 102,500 | -73% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $4.2m | 172,053 | 159% | added |
| Citadel Advisors | Q2 2026 | 0.0% | $4.0m | 163,571 | -36% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Millennium Management | 0.0% | $3.1m |
How has hedge fund ownership of GLUE changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 8 | $170.1m |
| Q1 2026 | 8 | $112.1m |
| Q4 2025 | 2 | $54.0m |
| Q3 2025 | 4 | $29.1m |
| Q2 2025 | 3 | $18.3m |
| Q1 2025 | 3 | $8.4m |
| Q4 2024 | 4 | $13.2m |
| Q3 2024 | 3 | $15.7m |
| Q2 2024 | 3 | $11.9m |
| Q1 2024 | 2 | $4.5m |
| Q4 2023 | 2 | $3.5m |
| Q3 2023 | 2 | $2.9m |
| Q2 2023 | 2 | $4.1m |
| Q1 2023 | 2 | $4.2m |
| Q4 2022 | 3 | $7.9m |
| Q3 2022 | 2 | $8.3m |
Counts every tracked manager that disclosed GLUE in that quarter's filing, including managers that have since stopped filing.